Inventor · disambiguated record
Michael Quirk
Also filed as: QUIRK MICHAEL · QUIRK MICHAEL C
3 granted patents·6 pending applications·3 citations·filing 2014–2022
58Inventor score
Top patents by PatentIndex Score
9 records- 0182US9822075B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2014·Granted Nov 21, 2017·3 cites·12 claims
- 0269US10815199B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2019·Granted Oct 27, 2020·0 cites·15 claims
- 0366US2023218638A1Neuroactive compounds and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0461US10207994B2NMDA antagonist prodrugsASTRAZENECA AB·Filed 2017·Granted Feb 19, 2019·0 cites·4 claims
- 0558US2025064833A1Combination of muscarinic receptor positive modulators and nmda positive allosteric modulatorsSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0658US2025319105A1Neuroactive steroid for the treatment of alzheimer's diseaseSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0756US2025041317A1Neuroactive steroid for the treatment of huntington's diseaseSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0854US2024252514A1Neuroactive steroid for the treatment of mild cognitive impairment associated with parkinson's diseaseSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0936US2017304321A1Neuroactive compounds and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Quirk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →